| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,708 |
5,965 |
$178K |
| 99215 |
Prolong outpt/office vis |
1,098 |
1,084 |
$49K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,746 |
2,438 |
$38K |
| 36410 |
|
2,120 |
2,007 |
$7K |
| G0181 |
Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allowed practitioner development and/or revision of care plans |
1,028 |
1,028 |
$3K |
| 99497 |
|
422 |
417 |
$2K |
| 99354 |
|
347 |
321 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
27 |
26 |
$2K |
| 92100 |
|
156 |
155 |
$2K |
| 90686 |
|
56 |
54 |
$916.40 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
89 |
86 |
$850.65 |
| 90662 |
|
723 |
707 |
$383.30 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
40 |
38 |
$301.73 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
27 |
25 |
$175.92 |
| 0012A |
|
16 |
16 |
$160.00 |
| 0011A |
|
15 |
15 |
$160.00 |
| 99422 |
|
15 |
15 |
$159.01 |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
15 |
15 |
$142.63 |
| 99498 |
|
422 |
417 |
$84.91 |
| G0454 |
Physician documentation of face-to-face visit for durable medical equipment determination performed by nurse practitioner, physician assistant or clinical nurse specialist |
138 |
136 |
$74.84 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
24 |
24 |
$65.87 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
24 |
24 |
$43.40 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
24 |
24 |
$37.68 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
24 |
24 |
$29.40 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
27 |
26 |
$23.46 |
| 82274 |
|
71 |
70 |
$13.37 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
1,078 |
1,067 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
242 |
237 |
$0.00 |
| 1125F |
|
13 |
13 |
$0.00 |
| 99355 |
|
344 |
318 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
730 |
715 |
$0.00 |
| 1170F |
|
85 |
84 |
$0.00 |
| 3072F |
|
12 |
12 |
$0.00 |
| 1126F |
|
38 |
38 |
$0.00 |
| 91301 |
|
12 |
12 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
26 |
25 |
$0.00 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
15 |
15 |
$0.00 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
13 |
13 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
236 |
231 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
87 |
87 |
$0.00 |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
40 |
40 |
$0.00 |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
15 |
15 |
$0.00 |